Fortrea
Kelly Woolard currently serves as a Clinical Research Associate II at Fortrea, a position held since May 2022, following experience at Labcorp Drug Development as a Clinical Research Associate from May 2022 to May 2023. Prior roles include In-House CRA and Clinical Trial Coordinator at Covance from August 2018 to May 2022, and Surgery Coordinator at Wilmington Eye from January 2016 to August 2018. Additional experience includes working as a Patient Care Coordinator at Retina Of Coastal Carolina from January 2015 to January 2016 and as a Manager at Carolina Storage from September 2013 to January 2015. Education includes a pending degree in Clinical Research Coordinator from Cape Fear Community College, with studies completed between 2017 and 2021.
This person is not in any teams
This person is not in any offices
Fortrea
13 followers
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of approximately 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com.